High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant

International Journal of Cancer

Volumn 132, Issue 3, 2013, Pages

  Flossbach, Lucia ^a   Holzmann, Karlheinz ^a   Mattfeldt, Torsten ^a   Buck, Michaela ^a   Lanz, Karin ^a   Held, Michael ^a   Möller, Peter ^a   Barth, Thomas F E ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

clonal evolution; gastrointestinal MZBL; lymphoma progression; SNP array

Indexed keywords

ADAM PROTEIN; BCL11A PROTEIN; ETS1 PROTEIN; KRAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; SCAPER PROTEIN; SIRPB1 PROTEIN; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CASE REPORT; CLONAL EVOLUTION; DIGESTIVE SYSTEM CANCER; GENETIC HETEROGENEITY; HUMAN; LARGE CELL LYMPHOMA; MALE; MARGINAL ZONE LYMPHOMA; MICROARRAY ANALYSIS; ONCOGENE BCL11A; ONCOGENE ETS1; ONCOGENE KRAS; ONCOGENE PTEN; ONCOGENE PTPN1; ONCOGENE REL; PRIORITY JOURNAL; PROTO ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM;

CASPASES; CLONAL EVOLUTION; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENES; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84870241138     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27774     Document Type: Article

References (43)

1. Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In:, Swerdlow SH, Campo E, Harris NL, et al., eds. World Health Organization Classification of Tumours of Hematopoietic and Lymphoid Tisues. Lyon: IARC press, 2008. 214-7.
2. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC press, 2008.
3. Barth TF, Barth CA, Kestler HA, et al. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 2007; 211: 305-13.
4. Barth TF, Bentz M, Leithäuser F, et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001; 31: 316-25.
5. Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-9.
6. Kuo SH, Yeh KH, Wu MS, et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood 2012; 119: 4838-44.
7. Möller P, Viardot A,. Antibiotics as first-line therapy for Hp-associated gastric large B-cell lymphoma? Probably yes. Blood 2012; 119: 4818-9.
8. Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood 2011; 117: 1595-604.
9. Kwee I, Rancoita PM, Rinaldi A, et al. Genomic profiles of MALT lymphomas: variability across anatomical sites. Haematologica 2011; 96: 1064-6.
10. Flossbach L, Antoneag E, Buck M, et al. BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Cancer 2011; 129: 70-7.
11. Barth TF, Döhner H, Werner CA, et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998; 91: 4321-30.
12. Dtsch Arztebl 2003; 100: A 1632.
13. Bengtsson H, Irizarry R, Carvalho B, et al. Estimation and assessment of raw copy numbers at the single locus level. Bioinformatics 2008; 24: 759-67.
14. Olshen AB, Venkatraman ES, Lucito R, et al. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004; 5: 557-72.
15. Eckel-Passow JE, Atkinson EJ, Maharjan S, et al. Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform. BMC Bioinformatics 2011; 12: 220.
16. Müller A, Holzmann K, Kestler HA,. Visualization of genomic aberrations using Affymetrix SNP arrays. Bioinformatics 2007; 23: 496-7.
17. van Rijk A, Mason D, Jones M, et al. Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. J Hematop 2008; 1: 119-26.
18. Barth TF, Martin-Subero JI, Joos S, et al. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Blood 2003; 101: 3681-6.
19. Martin-Subero JI, Gesk S, Harder L, et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-7.
20. Weniger MA, Pulford K, Gesk S, et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 2006; 20: 1880-2.
21. Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006; 8: 141-51.
22. Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003; 4: R28.
23. Neumann CA, Krause DS, Carman CV, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 2003; 424: 561-5.
24. Schafmayer C, Buch S, Egberts JH, et al. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 2007; 121: 555-8.
25. Lee JH, Kang Y, Khare V, et al. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene 2010; 29: 1431-50.
26. Isaacson PG, Du MQ,. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644-53.
27. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601-9.
28. Baens M, Steyls A, Dierlamm J, et al. Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT type. Genes Chromosomes Cancer 2000; 29: 281-91.
29. Liu H, Hamoudi RA, Ye H, et al. t(11;18)(q21;q21) of mucosa-associated lymphoid tissue lymphoma results from illegitimate non-homologous end joining following double strand breaks. Br J Haematol 2004; 125: 318-29.
30. Novak U, Rinaldi A, Kwee I, et al. The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 2009; 113: 4918-21.
31. Samuels Y, Waldman T,. Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol 2010; 347: 21-41.
32. Yang S,. Gene amplifications at chromosome 7 of the human gastric cancer genome. Int J Mol Med 2007; 20: 225-31.
33. Du MQ,. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 2007; 47: 31-42.
34. Toracchio S, Ota H, de JD, et al. Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas. Cancer Sci 2009; 100: 881-7.
35. Zhang Y, Yan LX, Wu QN, et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 2011; 71: 3552-62.
36. Lessard L, Stuible M, Tremblay ML,. The two faces of PTP1B in cancer. Biochim Biophys Acta 2010; 1804: 613-9.
37. O'Keefe C, McDevitt MA, Maciejewski JP,. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 2010; 115: 2731-9.
38. Wolfsberg TG, Primakoff P, Myles DG, et al. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 1995; 131: 275-8.
39. Barrow J, Mowicz-Brice M, Cartmill M, et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol 2011; 13: 212-22.
40. Tsang WY, Wang L, Chen Z, et al. SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression. J Cell Biol 2007; 178: 621-33.
41. Gaikwad S, Larionov S, Wang Y, et al. Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol 2009; 175: 2528-39.
42. Navin N, Krasnitz A, Rodgers L, et al. Inferring tumor progression from genomic heterogeneity. Genome Res 2010; 20: 68-80.
43. Navin NE, Hicks J,. Tracing the tumor lineage. Mol Oncol 2010; 4: 267-83.